The prognosis for Hodgkin Lymphoma has improved significantly over the past few decades due to advances in treatment. The five-year survival rate for patients with Hodgkin Lymphoma is now around 85-90%. Early-stage disease typically has a better prognosis compared to advanced-stage disease.
